Rituximab for Prevention of Chronic GVHD
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
UVB Phototherapy Treatment of Oral Chronic GVHD
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph II CHOP+Velcade in Mediastinal LBCL
- Status
- TERMINATED
- Phase
- PHASE2
SU011248 in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of PTK787/ZK 222584 Plus Paclitaxel
- Status
- TERMINATED
- Phase
- PHASE1
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2